These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3561294)

  • 1. Treatment of chronic active hepatitis and other liver diseases with corticosteroid agents.
    Mackay IR
    Med J Aust; 1987 Apr; 146(7):370-4. PubMed ID: 3561294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maintenance of remission in autoimmune chronic active hepatitis with azathioprine after corticosteroid withdrawal.
    Stellon AJ; Keating JJ; Johnson PJ; McFarlane IG; Williams R
    Hepatology; 1988; 8(4):781-4. PubMed ID: 3292363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune chronic active hepatitis responsive to immunosuppressive therapy evolving into a typical primary biliary cirrhosis syndrome: a case report.
    Horsmans Y; Piret A; Brenard R; Rahier J; Geubel AP
    J Hepatol; 1994 Aug; 21(2):194-8. PubMed ID: 7989708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relapse following treatment withdrawal in patients with autoimmune chronic active hepatitis.
    Hegarty JE; Nouri Aria KT; Portmann B; Eddleston AL; Williams R
    Hepatology; 1983; 3(5):685-9. PubMed ID: 6618435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azathioprine for long-term maintenance of remission in autoimmune hepatitis.
    Johnson PJ; McFarlane IG; Williams R
    N Engl J Med; 1995 Oct; 333(15):958-63. PubMed ID: 7666914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic liver diseases: current therapeutic options.
    Kaplan MM
    Hosp Pract (Off Ed); 1989 Mar; 24(3):111-6, 121-3, 126-30. PubMed ID: 2493463
    [No Abstract]   [Full Text] [Related]  

  • 7. [Corticosteroids and the liver. Metabolism and indications in liver diseases].
    Uribe M; Ramos MH
    Rev Invest Clin; 1983; 35(1):71-80. PubMed ID: 6346450
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of autoimmune chronic active hepatitis and of primary biliary cirrhosis].
    Renner EL
    Schweiz Med Wochenschr; 1994 Mar; 124(12):495-501. PubMed ID: 8159985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised controlled trial of azathioprine withdrawal in autoimmune chronic active hepatitis.
    Stellon AJ; Hegarty JE; Portmann B; Williams R
    Lancet; 1985 Mar; 1(8430):668-70. PubMed ID: 2858619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive therapy in chronic liver disease.
    Sherlock S
    Minerva Med; 1978 Aug; 69(38):2605-9. PubMed ID: 714260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effect of (+)-cyanidanol-3 in toxic alcoholic liver disease and in chronic active hepatitis.
    Abonyi M; Kisfaludy S; Szalay F
    Acta Physiol Hung; 1984; 64(3-4):455-60. PubMed ID: 6397971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mixed types of chronic active hepatitis and primary biliary cirrhosis associated with the anti-phospholipid antibody syndrome: a case report.
    Saeki R; Kaneko S; Terasaki S; Unoura M; Ogino H; Wakabayashi T; Kawara S; Nakanuma Y; Kobayashi K
    Hepatogastroenterology; 1993 Oct; 40(5):499-501. PubMed ID: 8270244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune cholangiopathy: part of the spectrum of autoimmune chronic active hepatitis.
    Ben-Ari Z; Dhillon AP; Sherlock S
    Hepatology; 1993 Jul; 18(1):10-5. PubMed ID: 8100797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive treatment of chronic HBsAg-positive hepatitis in childhood.
    Tolentino P; Jannuzzi C; Giacchino R
    Infection; 1983; 11(5):255-9. PubMed ID: 6642677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic active hepatitis in the elderly.
    Selby CD; Toghill PJ
    Age Ageing; 1986 Nov; 15(6):350-6. PubMed ID: 3799364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical use of corticosteroid and immunosuppressive drugs in liver disease.
    Fung WP
    Drugs; 1974; 8(2):139-45. PubMed ID: 4434868
    [No Abstract]   [Full Text] [Related]  

  • 17. Epigenetic considerations and the clinical reevaluation of the overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis.
    Wang Q; Selmi C; Zhou X; Qiu D; Li Z; Miao Q; Chen X; Wang J; Krawitt EL; Gershwin ME; Han Y; Ma X
    J Autoimmun; 2013 Mar; 41():140-5. PubMed ID: 23187010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppressive treatment of chronic liver disease.
    Jones EA; Bergasa NV
    Ann N Y Acad Sci; 1993 Nov; 696():319-27. PubMed ID: 8109838
    [No Abstract]   [Full Text] [Related]  

  • 19. Idiopathic chronic active hepatitis: a diagnostic and therapeutic dilemma.
    Al-Fadda M; Zafar M; Ayub A; al-Kahtani K
    J Clin Gastroenterol; 1994 Dec; 19(4):313-7. PubMed ID: 7876513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features and prognostic implications of severe corticosteroid-treated cryptogenic chronic active hepatitis.
    Czaja AJ; Hay JE; Rakela J
    Mayo Clin Proc; 1990 Jan; 65(1):23-30. PubMed ID: 2296210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.